Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2025 23:12 ET | Source: Senseonics Holdings, Inc.

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable...
May 15, 2025 16:05 ET | Source: Senseonics Holdings, Inc.

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

GERMANTOWN, Md., May 15, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable...
May 08, 2025 16:05 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Reports First Quarter Financial Results

Q1 Revenue of $6.3 million, growth year over year of 24% Partnership with Sequel integrates twiist™ automated insulin delivery (AID) system with Eversense® 365 one-year continuous glucose monitor...
April 29, 2025 16:05 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

GERMANTOWN, Md., April 29, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
April 29, 2025 07:30 ET | Source: Senseonics Holdings, Inc.

Sequel Med Tech and Senseonics Integrate Technologies to Create First Automated Insulin Delivery (AID) System with One-Year Continuous Glucose Monitor (CGM)

twiist™ expands compatibility offerings to become the first AID system compatible with Senseonics Eversense® 365 one-year CGM system twiist with Eversense 365 launch expected in Q3 MANCHESTER, N.H....
March 03, 2025 16:05 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Received FDA approval for Eversense® 365 Continuous Glucose Monitoring system and launched Eversense 365 with commercial partner, Ascensia Patient base increased 56% in 2024 over 2023 to...
February 26, 2025 07:30 ET | Source: Senseonics Holdings, Inc.

Eversense 365 and SweetSpot Integrate Software to Optimize Diabetes Care

Senseonics and Ascensia integrate software between SweetSpot and Eversense 365, the world’s first and only One Year CGM system SweetSpot partners with endocrinology practices to provide virtual CGM...
February 13, 2025 16:05 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. to Participate in the TD Cowen 45th Annual Health Care Conference

GERMANTOWN, Md., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
February 12, 2025 16:07 ET | Source: Senseonics Holdings, Inc.

Senseonics Holdings, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call for March 3, 2025 at 4:30 P.M. Eastern Time

GERMANTOWN, Md., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term,...
February 06, 2025 16:05 ET | Source: Senseonics Holdings, Inc.

Senseonics Completes CE Mark Submission for Eversense 365, World’s Longest-lasting Continuous Glucose Monitor

GERMANTOWN, Md., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable...